MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Subjective cognitive complaints assessed with the cognitive domain of the Non-Motor Symptoms Scale predict longitudinal cognitive trajectory in people with Parkinson’s disease with normal cognition

L. Batzu, DJ. van Wamelen, D. Urso, V. Leta, A. Podlewska, K. Rukavina, J. Staunton, YM. Wan, A. Rizos, K. Ray Chaudhuri (London, United Kingdom)

Meeting: MDS Virtual Congress 2021

Abstract Number: 664

Keywords: Cognitive dysfunction, Non-motor Scales, Parkinson’s

Category: Parkinson's Disease: Cognitive functions

Objective: To investigate whether subjective cognitive complaints assessed by the Non-Motor Symptoms Scale (NMSS) are predictive of longitudinal cognitive trajectories in cognitively intact people with Parkinson’s (PwP).

Background: Evidence suggests that subjective cognitive complaints (SCC), reported in the absence of a manifest objective cognitive impairment, may be a harbinger of future cognitive decline in Parkinson’s disease (PD) [1]. Reliable tools for the assessment or screening of SCC in PD are currently lacking [2], and identification of this potential predictor of cognitive decline in clinical practice is an unmet need.

Method: Data for this study were obtained from the Non-Motor Longitudinal International Study (NILS, initiated in 2010). We included PwP with a diagnosis of idiopathic PD according to the UK Brain Bank criteria and a Mini-Mental State Examination (MMSE) score of 30 at baseline, indicating the absence of any cognitive disorder on a screening basis [3]. The Attention/Memory domain (Domain 5) of the NMSS [4] evaluates subjective memory and attentional issues over the previous month using a score based on the frequency and severity of complaints (total domain score range 0-36). The relationship of baseline NMSS Domain 5 with longitudinal changes in MMSE scores was assessed using linear mixed effects models (LMM) and adjusting for potential confounders (age, sex, education, motor function and depression).

Results: A total of 413 PwP [median age 64.4 (56.0-70.7)] and up to 3 years of follow-up were included in the current analysis (Table 1). A first LMM, which included the NMSS Domain 5 score as continuous predictor of MMSE decline, displayed a significant interaction between time and NMSS Domain 5 score (p=0.004) (Table 2). Similarly, when the NMSS Domain 5 was used as categorical predictor for the absence (0) or presence (≥1) of any cognitive complaints in a second LMM, a significant interaction with time was confirmed (p=0.016) (Table 2, Figure).

Conclusion: Although in our cohort we detected a mild decline in MMSE score after 3 years, our findings suggest that in PwP without manifest cognitive impairment the assessment of SCC using specifically Domain 5 of NMSS may provide insights into future cognitive progression and offer opportunities for potential early therapeutic interventions.

Table 1

Table 2

Figure

References: 1. Purri R, Brennan L, Rick J, Xie SX, Deck BL, Chahine LM, Dahodwala N, Chen-Plotkin A, Duda JE, Morley JF, Akhtar RS, Trojanowski JQ, Siderowf A, Weintraub D. Subjective Cognitive Complaint in Parkinson’s Disease Patients With Normal Cognition: Canary in the Coal Mine? Mov Disord. 2020 Sep;35(9):1618-1625. doi: 10.1002/mds.28115. Epub 2020 Jun 10. PMID: 32520435; PMCID: PMC7722141. 2. Kjeldsen PL, Damholdt MF. Subjective cognitive complaints in patients with Parkinson’s disease. Acta Neurol Scand. 2019 Dec;140(6):375-389. doi: 10.1111/ane.13158. Epub 2019 Oct 9. PMID: 31433855. 3. Hoops S, Nazem S, Siderowf AD, Duda JE, Xie SX, Stern MB, Weintraub D. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology. 2009 Nov 24;73(21):1738-45. doi: 10.1212/WNL.0b013e3181c34b47. PMID: 19933974; PMCID: PMC2788810. 4. Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P, Ondo W, Abe K, Macphee G, Macmahon D, Barone P, Rabey M, Forbes A, Breen K, Tluk S, Naidu Y, Olanow W, Williams AJ, Thomas S, Rye D, Tsuboi Y, Hand A, Schapira AH. The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: Results from an international pilot study. Mov Disord. 2007 Oct 15;22(13):1901-11. doi: 10.1002/mds.21596. PMID: 17674410.

To cite this abstract in AMA style:

L. Batzu, DJ. van Wamelen, D. Urso, V. Leta, A. Podlewska, K. Rukavina, J. Staunton, YM. Wan, A. Rizos, K. Ray Chaudhuri. Subjective cognitive complaints assessed with the cognitive domain of the Non-Motor Symptoms Scale predict longitudinal cognitive trajectory in people with Parkinson’s disease with normal cognition [abstract]. Mov Disord. 2021; 36 (suppl 1). https://www.mdsabstracts.org/abstract/subjective-cognitive-complaints-assessed-with-the-cognitive-domain-of-the-non-motor-symptoms-scale-predict-longitudinal-cognitive-trajectory-in-people-with-parkinsons-disease-with-normal-cogn/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2021

MDS Abstracts - https://www.mdsabstracts.org/abstract/subjective-cognitive-complaints-assessed-with-the-cognitive-domain-of-the-non-motor-symptoms-scale-predict-longitudinal-cognitive-trajectory-in-people-with-parkinsons-disease-with-normal-cogn/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley